Novel Bone-targeted Agents for Treatment of Osteoporosis

被引：0
|
作者：
Jun Bo WANG
机构：
来源：
Chinese Chemical Letters | 2005年 / 07期
关键词：
Osteoporosis; bone-targeted; raloxifene; bisphosphonate;
D O I：
暂无
中图分类号：
R58 [内分泌腺疾病及代谢病];
学科分类号：
摘要：
The novel bone-targeted agents were designed and synthesized by the combination of raloxifene and bisphosphonates. The anti-osteoporosis effect was evaluated by bone mineral density (BMD) obtained from OVX mice in vivo. The results indicated that the compound 8, 9 not only prevented ovariectomy induced loss of bone but also enhanced BMD to 0.87% and 19.67% compared to Sham, respectively.
引用
收藏
页码：859 / 862
页数：4
相关论文
共 50 条
  • [31] Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis
    Dou, Ce
    Li, Jianmei
    He, Jian
    Luo, Fei
    Yu, Tao
    Dai, Qijie
    Chen, Yueqi
    Xu, Jianzhong
    Yang, Xiaochao
    Dong, Shiwu
    BIOACTIVE MATERIALS, 2021, 6 (12) : 4697 - 4706
  • [32] Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosis
    Liu, Han
    Zhang, Hao
    Wang, Sicheng
    Cui, Jin
    Weng, Weizong
    Liu, Xinru
    Tang, Hua
    Hu, Yan
    Li, Xiaoqun
    Zhang, Kun
    Zhou, Fengjin
    Jing, Yingying
    Su, Jiacan
    COMPOSITES PART B-ENGINEERING, 2023, 225
  • [33] Bone-Targeted Extracellular Vesicles from Mesenchymal Stem Cells for Osteoporosis Therapy
    Wang, Yayu
    Yao, Jie
    Cai, Lizhao
    Liu, Tong
    Wang, Xiaogang
    Zhang, Ye
    Zhou, Zhiying
    Li, Tingwei
    Liu, Minyi
    Lai, Renfa
    Liu, Xiangning
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 7967 - 7977
  • [34] Bone-targeted engineered bacterial extracellular vesicles delivering miRNA to treat osteoporosis
    Liu H.
    Wu Y.
    Wang F.
    Wang S.
    Ji N.
    Wang M.
    Zhou G.
    Han R.
    Liu X.
    Weng W.
    Tan H.
    Jing Y.
    Zhang W.
    Zhang H.
    Shi Z.
    Su J.
    Composites Part B: Engineering, 2023, 267
  • [35] Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis
    Katsumi, Hidemasa
    Yamashita, Shugo
    Morishita, Masaki
    Yamamoto, Akira
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (07) : 560 - 566
  • [36] Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis
    Xing, Xiaotao
    Tang, Qi
    Zou, Jiaojiao
    Huang, Haisen
    Yang, Jian
    Gao, Xin
    Xu, Xun
    Ma, Shixing
    Li, Maojiao
    Liang, Cheng
    Tan, Lin
    Liao, Li
    Tian, Weidong
    ACTA BIOMATERIALIA, 2023, 157 : 352 - 366
  • [37] De-escalation of bone-targeted agents for metastatic prostate cancer
    Hong, Brian Younho
    Ibrahim, Mohammed F. K.
    Fernandes, Ricardo
    Mazzarello, Sasha
    Hutton, Brian
    Shorr, Risa
    Clemons, Mark
    CURRENT ONCOLOGY, 2016, 23 (01) : E77 - E78
  • [38] Bone-Targeted Agents in Early Breast Cancer: Part of Standard Practice?
    Brufsky, Adam M.
    ONCOLOGY-NEW YORK, 2018, 32 (11): : 565 - 565
  • [39] Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis
    Chen, Zhong-Hua
    Du, De-Yan
    Fu, Yi-Fei
    Wu, Jun-Jie
    Guo, Dan-Yang
    Li, Yue-Yue
    Chen, Meng-Nan
    Yuan, Zheng-Dong
    Zhang, Kai-Wen
    Zhang, Zhen-Yu
    Li, Xia
    Yuan, Feng-Lai
    MATERIALS TODAY BIO, 2023, 22
  • [40] Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany
    Hartmut Link
    Ingo Diel
    Carsten-H. Ohlmann
    Laura Holtmann
    Markus Kerkmann
    Supportive Care in Cancer, 2020, 28 : 2175 - 2184
12345